Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP deviations.
- Products
-
- fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride
- Company
- Wells Pharma of Houston LLC
- Where it was sold
-
U.S. Nationwide.
Nationwide
- Units affected
- 50 syringes
- About this recall
- fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.